title: Oral submucosal fibrosis in Iran: a case review.
authors.affiliation: Imam University Hospital, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Parvin
authors.initials: P
authors.lastname: Mansouri
authors.forename: Shideh
authors.initials: S
authors.lastname: Yazdanian
authors.forename: Farid
authors.initials: F
authors.lastname: Safar
authors.forename: Ramin
authors.initials: R
authors.lastname: Espandar
authors.forename: Samad
authors.initials: S
authors.lastname: Rezaii
authors.forename: Zahra
authors.initials: Z
authors.lastname: Safaie-Naraghi
authors.forename: Reza
authors.initials: R
authors.lastname: Chalangari
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001114:Areca / Q000009:adverse effects*; D002710:Chlorhexidine / Q000627:therapeutic use; D005081:Exercise Therapy; D006801:Humans; D007492:Iran; D008297:Male; D009067:Mouthwashes / Q000627:therapeutic use; D009914:Oral Submucous Fibrosis / Q000473:pathology* / Q000534:rehabilitation / Q000628:therapy*; D040242:Risk Reduction Behavior; D014030:Tobacco, Smokeless / Q000009:adverse effects; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D009067:Mouthwashes; D014222:Triamcinolone Acetonide; D002710:Chlorhexidine